tiprankstipranks
PharmAla Biotech Holdings, Inc. (TSE:MDMA)
:MDMA
Canadian Market

PharmAla Biotech Holdings, Inc. (MDMA) Cash flow

Compare
57 Followers

PharmAla Biotech Holdings, Inc. Cash Flow

TSE:MDMA's free cash flow for Q1 2025 was C$-263.33K. For the 2025 fiscal year, TSE:MDMA's free cash flow was decreased by C$298.61K and operating cash flow was C$-238.89K. See a summary of the company’s cash flow.
Cash Flow
Sep 24Sep 23Sep 22Sep 21
Operating Cash Flow
C$ -321.36KC$ -339.66KC$ -625.37KC$ -173.57K
Investing Cash Flow
C$ -226.42KC$ -506.74KC$ -994.87KC$ 629.22K
Financing Cash Flow
C$ 772.12KC$ 189.29KC$ 0.00C$ 2.02M
End Cash Position
C$ 419.38KC$ 195.04KC$ 852.14KC$ 2.47M
Free Cash Flow
C$ -547.78KC$ -846.39KC$ -1.62MC$ -435.76K
Currency in CAD

PharmAla Biotech Holdings, Inc. Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis